Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgen Suppression + EBRT + Brachytherapy in Intermediate Risk Prostate Cancer
NCT00006359Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 2000
- Primary completion
- Oct 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide, goserelin, flutamide, bicalutamide in prostate cancer (PCa), sponsored by Cancer and Leukemia Group B. Started Sep 2000; status: completed.
02
Drugs
leuprolidegoserelinflutamidebicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00006359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006359.